This is a demo store. No orders will be fulfilled.

Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 03 Jul 2019  |  Global  |  Market Research

    Global Employee Health Management IT Market, Forecast to 2024

    Well-Being and Corporate Performance are Top Priorities

    The purpose of this research service is to present a comprehensive analysis of the global employee health management information technology (EHM IT) market, with respect to how digital health platforms are expected to help employers devise and scale clinical and wellness programs that ensure employee well-being and improve organizational productivi...

    $4,950.00
  2. 24 Jun 2019  |  North America  |  Market Research

    US Clinical Decision Support Systems Market, Forecast to 2024

    A Growing Market with an Opportunity to be More than an Adjunct to the EHR

    Clinical Decision Support (CDS) systems are poised to become the user interface of choice for clinical interaction with health IT, ultimately supplanting the EHR system as the primary health IT point of interface for clinicians. This is due the fact that CDS began as a way to deliver medical content and patient information to the caregiver. Unlike ...

    $4,950.00
  3. 21 Jun 2019  |  Asia Pacific  |  Market Research

    Chinese In-vitro Diagnostics Market Insight, Forecast to 2023

    The China Manufacturing 2025 Program for Promoting Local R&D Investments and Increasing Demand from Tier I and II Hospitals Set to Transform the Industry Landscape

    The In-vitro Diagnostics (IVD) market in China shows strong growth potential in several segments. Market growth is set to be driven by the growing volume of tests, rather than the higher price of testing solutions in traditional segments and the popularization of advanced testing technology in emerging segments. In the context of the reform in publ...

    $1,500.00
  4. 17 Jun 2019  |  Asia Pacific  |  Market Research

    Regulatory Trends in Select Asian Bone Mineral Density Solutions, 2017

    Unchanged Regulatory Process for DXA-BMD Device Approval Makes it Easier for Market Adoption

    This study carries Frost & Sullivan’s observation of bone mineral density solutions in select Asian Countries (Australia, South Korea, and China); the regulatory trends for the same have been covered, highlighting the following: • Product registration and regulatory approval process details in select Asian countries (such as the Therapeutic Goo...

    $1,500.00
  5. 14 Jun 2019  |  Global  |  Technology Alert

    Recent Innovations in Biopharmaceutical and Biomarker Technologies

    This edition of the Life Science, Health & Wellness TechVision Opportunity Engine (TOE) comprises 26 recent technology innovations across the biopharmaceutical and biomarker platforms for research and clinical applications across the global healthcare industry. The research captures key innovation aspects such as technology readiness levels, marke...

    $950.00
  6. The latest issue of Advanced MedTech TechVision Opportunity Engine (TOE) profiles a diverse range of early-stage and pre-commercialization technologies. Mining deep into academia research, TechVision has unearthed innovative and potentially transformative technologies that are currently being developed in research labs and in universities across th...

    $950.00
  7. This edition of the Inside R&D TechVision Opportunity Engine (TOE) depicts innovations in CRISPR-based gene editing systems for the treatment of inherited lung diseases. It also provides intelligence on the use of biopsy platforms for early detection of cancer. The TOE also features innovations based on the utilization of blood tests that can detec...

    $950.00
  8. 07 Jun 2019  |  North America  |  Market Research

    Healthcare Infrastructure and Procedural Volume for Ultrasound Imaging, 2018

    New Clinical Applications and Value Offerings will Create Growth Opportunities Globally

    This research insight aims to provide an analysis of healthcare infrastructure and the procedural volume of using ultrasound, in the global market in 2018. Ultrasound machines are becoming lighter, more portable, and compact due to advances in a number of areas of technology (e.g., scan mode, image retrieval, and operation system) and especially b...

    $1,500.00
  9. 07 Jun 2019  |  Asia Pacific  |  Market Research

    Growth Insights in APAC Infectious Disease Point-of-Care Testing (POCT) Market, Forecast to 2023

    The Rising Prevalence of TB, HIV, and Hepatitis, Accompanied by the Development of Portable POCT Devices will Propel the APAC Infectious Diseases POCT Market

    This study presents an overview of the Asia-Pacific infectious disease point-of-care testing (POCT) market with an emphasis on some of the key trends and growth opportunities that are shaping the market. The study highlights some of the emerging business models supporting the development and adoption of innovative diagnostic tests. The Asia-Pacif...

    $3,000.00
  10. 29 May 2019  |  North America  |  Market Research

    Fiducial Markers for Lung and Prostate Cancer in Europe and US, Forecast to 2022

    Improved Accuracy for Localization of Radiotherapy Treatment to Drive the Demand for Fiducial Markers

    15 to 20 million new cases of cancer are diagnosed every year. Radiotherapy is the gold standard for treatment and is used on more than 3.5 million people and provided as palliative or adjunct treatment for an additional 3.5 million people, worldwide. Nearly 50 percent of all cancer patients are estimated to benefit from radiotherapy for disease ma...

    $1,500.00